4.455
price down icon8.52%   -0.415
after-market Handel nachbörslich: 4.54 0.085 +1.91%
loading

Finanzdaten der Voyager Therapeutics Inc-Aktie (VYGR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
14.75%
15.34
13.37 5.20 6.473 6.278
Operating Expenses
2.98%
45.27
43.96 41.83 41.17 44.58
Benefits Costs and Expenses
3.83%
42.75
41.17 38.57 37.46 40.18
Costs And Expenses
3.83%
42.75
41.17 38.57 37.46 40.18
Operating Income/Loss
2.16%
-29.93
-30.59 -36.62 -34.69 -38.30
Nonoperating Income/Loss
9.69%
2.515
2.785 3.258 3.709 4.396
Income/Loss From Continuing Operations Before Tax
1.41%
-27.42
-27.81 -33.37 -30.98 -33.90
Income Tax Expense/Benefit
89.16%
0.009
0.083 0.015 0.037 0.584
Income/Loss From Continuing Operations After Tax
1.67%
-27.43
-27.89 -33.38 -31.02 -34.49
Net Income/Loss
1.67%
-27.43
-27.89 -33.38 -31.02 -34.49
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.86%
0.0831
58.80 58.67 58.35 0.1031
Diluted Average Shares
99.86%
0.0831
58.80 58.67 58.35 0.1031
Basic Earnings Per Share
0.00%
-0.47
-0.47 -0.57 -0.53 -0.60
Diluted Earnings Per Share
0.00%
-0.47
-0.47 -0.57 -0.53 -0.60
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):